Proteomics identifies complement protein signatures in patients with primary biliary cholangitis

Area of Science:

• Immunology
• Hepatology
• Proteomics

Background:

• Primary biliary cholangitis (PBC) is an autoimmune liver disease with limited diagnostic and prognostic biomarkers.
• Current diagnostic and prognostic tools for PBC require improvement.

Purpose of the Study:

• To identify plasma complement biomarkers for improved diagnosis and prognosis of PBC.
• To evaluate the diagnostic and prognostic potential of identified complement components in PBC patients.

Main Methods:

• Analysis of large-scale proteomic data from the UK Biobank.
• Comparison of complement protein levels in 44 PBC patients and matched controls.
• Statistical analysis to assess diagnostic and prognostic accuracy, including comparison with the FIB-4 index.

Main Results:

• Significantly elevated levels of complement proteins (CR1, C1QA, C1QL2, C7, C9) were found in PBC patients.
• CR1, C1QA, C1QL2, and C7 showed strong diagnostic potential.
• CR1 demonstrated the highest predictive accuracy for adverse outcomes (AUC=81.85%), surpassing the FIB-4 index (AUC=76.33%).
• Specific complement components were associated with PBC onset risk and liver outcome severity.

Conclusions:

• Complement components, particularly CR1, are potential valuable biomarkers for PBC diagnosis.
• CR1 and other identified complement proteins can aid in predicting PBC severity and adverse outcomes.
• These findings may lead to improved clinical management of PBC.